BIIB logo

BIIB
Biogen Inc

18,620
Mkt Cap
$32.07B
Volume
27.00
52W High
$202.41
52W Low
$110.04
PE Ratio
21.36
BIIB Fundamentals
Price
$184.02
Prev Close
$188.05
Open
$185.01
50D MA
$181.80
Beta
0.62
Avg. Volume
1.45M
EPS (Annual)
$8.79
P/B
1.51
Rev/Employee
$1.27M
$28,730.03
Loading...
Loading...

About

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
7,500

Frequently Asked Questions

What is Market Cap of Biogen Inc?
What is the 52-week high for Biogen Inc?
What is the 52-week low for Biogen Inc?
What is Biogen Inc stock price today?
What was Biogen Inc stock price yesterday?
What is the PE ratio of Biogen Inc?
What is the Price-to-Book ratio of Biogen Inc?
What is the 50-day moving average of Biogen Inc?
How many employees does Biogen Inc have?

Latest BIIB News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.